![]() |
市场调查报告书
商品编码
1964165
医用相机市场-全球产业规模、份额、趋势、机会、预测:按应用、技术、地区和竞争格局划分,2021-2031年Medical Cameras Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Technology (Digital imaging, Infrared, OCT, Liquid lens technology), By Region & Competition, 2021-2031F |
||||||
全球医用相机市场预计将从 2025 年的 32.4 亿美元成长到 2031 年的 45.6 亿美元,复合年增长率为 5.86%。
医用相机,包括内视镜、显微镜和皮肤科相机,旨在捕捉解剖结构的高解析度影像,用于诊断和手术。这一市场成长的主要驱动力是文明病的日益普遍以及全球人口老化导致医疗需求的增加。此外,微创手术的广泛普及也推动了对高清视觉化工具的需求,这些工具能够确保患者安全并缩短復原时间。美国癌症协会预测,到2025年,美国将新增154,270例大肠癌病例,凸显了对强大诊断影像能力的迫切需求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 32.4亿美元 |
| 市场规模:2031年 | 45.6亿美元 |
| 复合年增长率:2026-2031年 | 5.86% |
| 成长最快的细分市场 | 内视镜检查 |
| 最大的市场 | 北美洲 |
然而,高画质和3D摄影系统需要大量的资本投入,这为市场带来了许多障碍。高成本对开发中国家的医疗机构而言是一个难题,限制了高性能设备的普及。此外,能够操作这些复杂影像技术的训练有素的医护人员长期短缺,也是限制市场渗透的一大挑战。
微创手术的日益普及是市场成长的主要驱动力,因为这些技术高度依赖高性能视觉化系统来引导。医院和门诊手术中心正优先部署整合先进摄影机技术的机器人辅助平台,以改善临床疗效并减轻病患负担。这种向技术依赖型手术的转变导致手术数量显着增加,从而对相容的成像设备产生了持续的需求。例如,Intuitive Surgical 在 2024 年 10 月发布的 2024 年第三季财报中指出,与 2023 年第三季相比,全球达文西手术数量增加了约 18%,这表明需要专用光学元件的机器人系统的使用量激增。
同时,高清3D成像技术的进步正迫使医疗机构升级其诊断基础设施。製造商正在推出具有更高深度感知和清晰度的设备,这对于检测传统模拟系统难以发现的病变至关重要。这个创新週期刺激了设备更新换代的需求,即使在成熟市场也吸引了投资。根据史赛克公司于2024年10月发布的2024年第三季业绩报告,内视镜部门的净销售额年增11.2%,显示现代视觉化工具的商业性应用十分强劲。这些采购趋势得益于医疗保健产业不断增长的资金投入。美国医疗保险和医疗补助服务中心(CMS)预测,到2032年,全国医疗保健支出将以每年平均5.6%的速度成长,这将为购置资本设备提供必要的财务环境。
先进医疗影像系统所需的大量资本投入是限制全球医用相机市场成长的主要障碍。高解析度和3D相机技术需要复杂的工程设计和昂贵的组件,导致价格高昂,对医疗机构的预算带来沉重负担。对于资源分配极为有限的开发中国家的小规模医疗机构和医院而言,这种经济负担尤其严重。因此,这些机构往往会推迟购买新设备或继续使用过时的系统,这直接限制了现代诊断影像设备的销售和市场渗透率。
成本壁垒的影响因当前整个医疗保健行业普遍面临的财务压力而进一步加剧。随着医院营运成本的不断上涨,用于新技术资本支出的预算往往被削减。根据美国医院协会统计,2024年医院总支出增加了5.1%。营运成本的增加凸显了该行业的财务困境,减少了可用于投资高端医用相机的资源。因此,潜在买家被迫优先考虑眼前的营运稳定性,而非购买先进的诊断工具,从而减缓了市场接受度。
市场正经历重大变革,即将人工智慧 (AI) 演算法整合到视觉化系统中,以提高即时病变检测的准确性。与标准的高解析度升级不同,这些智慧型系统利用电脑辅助检测技术,在萤幕上迭加视觉标记。这使得医生能够识别出传统技术可能遗漏的癌前息肉。这项技术已经超越了理论阶段,正朝着在公共卫生基础设施中大规模部署的方向发展。例如,在2024年11月题为「Medtronic透过与美国退伍军人事务部 (VA) 的合约扩展 GI Genius AI 技术」的新闻稿中,Medtronic宣布向美国退伍军人事务部 (VA) 下属的140多家机构部署了超过360台配备 GI Genius AI 的内视镜) 下属的140多家机构部署了超过360台配备 GI Genius AI 的内视镜,这展现了人工智慧商业性诊断工具。
同时,一次性内视镜摄影机的普及正在改变采购模式,消除了可重复使用设备相关的交叉感染风险和高成本的再处理流程。医疗机构越来越多地选择在预计使用量大的专业领域使用无菌预包装摄影机系统,从而确保设备的即时可用性,并在无需大量前期资本投入的情况下提高工作流程效率。这种从资本密集型设备向耗材解决方案的转变,正在推动专注于一次性光学的製造商实现显着的收入成长。根据Amb公司于2024年11月发布的2023/24年度报告,该公司内视镜解决方案部门在该财年实现了19.7%的内部成长,这主要得益于泌尿系统和耳鼻喉科领域对一次性设备的强劲需求。
The Global Medical Cameras Market is projected to expand from a valuation of USD 3.24 Billion in 2025 to USD 4.56 Billion by 2031, progressing at a CAGR of 5.86%. Medical cameras, which encompass instruments such as endoscopes, microscopes, and dermatology cameras, are engineered to capture high-resolution images of anatomical structures for both diagnostic and surgical purposes. This market growth is primarily underpinned by the increasing prevalence of chronic lifestyle-related conditions and an aging global population that necessitates frequent medical care. Additionally, the widespread shift toward minimally invasive procedures fuels the demand for high-definition visualization tools that ensure patient safety and shorten recovery periods. According to the American Cancer Society, an estimated 154,270 new colorectal cancer cases are expected to be diagnosed in the United States in 2025, highlighting the critical need for robust diagnostic imaging capabilities.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.24 Billion |
| Market Size 2031 | USD 4.56 Billion |
| CAGR 2026-2031 | 5.86% |
| Fastest Growing Segment | Endoscopy |
| Largest Market | North America |
However, the market faces significant hurdles due to the substantial capital investment required for high-definition and 3D camera systems. This high cost creates a barrier for healthcare facilities in developing nations, restricting the adoption of high-performance devices. Furthermore, a persistent shortage of trained medical professionals capable of operating these complex imaging technologies remains a challenge that limits broader market penetration.
Market Driver
The increasing adoption of minimally invasive surgical procedures serves as a major catalyst for market growth, as these techniques rely heavily on high-performance visualization systems for guidance. Hospitals and ambulatory surgical centers are prioritizing robotic-assisted platforms that incorporate advanced camera technologies to enhance clinical outcomes and reduce patient trauma. This transition toward technology-dependent surgeries has led to a measurable rise in procedural volumes, creating consistent demand for compatible imaging units. For instance, Intuitive Surgical reported in their Q3 2024 Financial Results in October 2024 that worldwide da Vinci procedures increased by approximately 18% compared to the third quarter of 2023, reflecting the intense utilization of robotic systems that require specialized optical components.
Concurrently, technological advancements in high-definition and 3D imaging are driving healthcare providers to upgrade their diagnostic infrastructure. Manufacturers are introducing devices with improved depth perception and clarity, which are essential for detecting pathologies that older analog systems might miss. This innovation cycle stimulates replacement sales and attracts investment even in established markets. According to Stryker's Third Quarter 2024 Operating Results from October 2024, Endoscopy net sales rose by 11.2% year-over-year, demonstrating the strong commercial uptake of modern visualization tools. These procurement trends are supported by increased financial commitments to the medical sector; the Centers for Medicare & Medicaid Services projected in 2024 that national health expenditure will grow at an average annual rate of 5.6% through 2032, providing the necessary fiscal environment for capital equipment acquisition.
Market Challenge
The substantial capital investment required for advanced medical imaging systems constitutes a major barrier to the growth of the Global Medical Cameras Market. High-definition and 3D camera technologies necessitate sophisticated engineering and expensive components, resulting in premium pricing that strains the budgets of healthcare providers. This financial burden is especially severe for smaller facilities and hospitals in developing nations where resource allocation is tightly constrained. Consequently, these institutions often postpone purchasing new equipment or persist in using legacy systems, which directly limits sales volumes and the market penetration of modern imaging devices.
The impact of this cost barrier is intensified by the broader financial pressures currently affecting the healthcare sector. As hospitals contend with rising operational costs, capital expenditure budgets for new technologies are frequently curtailed. According to the American Hospital Association, total hospital expenses increased by 5.1% in 2024. This rise in operational spending highlights the financial tightness within the industry, leaving fewer resources available for investing in high-end medical cameras. As a result, the market experiences slower adoption rates, as potential buyers are forced to prioritize immediate operational stability over the acquisition of advanced diagnostic tools.
Market Trends
The market is undergoing a significant shift toward integrating artificial intelligence (AI) algorithms into visualization systems to improve real-time lesion detection. Unlike standard high-definition upgrades, these intelligent systems employ computer-aided detection to overlay visual markers on the screen, helping physicians identify pre-cancerous polyps that might otherwise be missed during procedures. This technology is moving beyond theoretical concepts to large-scale deployment in public health infrastructure. For example, Medtronic announced in a November 2024 press release titled 'Medtronic awarded VA contract to expand GI Genius AI technology' that it had installed over 360 GI Genius AI-powered endoscopy units across more than 140 U.S. Department of Veterans Affairs facilities, demonstrating the rapid commercial validation of AI-enhanced diagnostic tools.
Simultaneously, the widespread adoption of single-use endoscopic cameras is transforming procurement models by eliminating cross-contamination risks and the costly reprocessing cycles associated with reusable devices. Healthcare providers are increasingly choosing sterile, pre-packaged camera systems for high-volume specialties to ensure immediate device availability and enhance workflow efficiency without incurring heavy upfront capital costs. This transition from capital-intensive equipment to consumable-based solutions is driving significant revenue growth for manufacturers focused on disposable optics. According to Ambu's Annual Report 2023/24 published in November 2024, the company reported that its Endoscopy Solutions revenue increased organically by 19.7% for the fiscal year, driven largely by the robust adoption of single-use devices in the urology and ENT segments.
Report Scope
In this report, the Global Medical Cameras Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Medical Cameras Market.
Global Medical Cameras Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: